Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
KLRK1 (Killer cell lectin like receptor K1) encodes a type‑II transmembrane C‑type‑lectin‑like glycoprotein localizing predominantly to plasma‑membrane compartments of innate‑and‑adaptive immune‑lineage cell populations. This protein is detectable across subsets of immune cell populations and exhibits cell‑subset‑restricted, stimulus‑sensitive tissue‑level expression patterns. Distinct from purely soluble intracellular factors, it carries a short cytosolic N‑terminal segment, single transmembrane helix and extracellular C‑terminal lectin‑like domain and lacks standalone intracellular catalytic modules. It acts as a membrane‑resident receptor subunit, cooperating with auxiliary membrane‑embedded adaptor components to shape immune‑cell‑surface‑associated molecular arrangements under physiological conditions. Insufficient adequate KLRK1 protein abundance could disturb normal surface receptor‑partner complex assembly and interfere with downstream immune‑cell membrane adaptive properties. KLRK1 may provide molecular buffering to sustain appropriate receptor‑dependent molecular arrangement across immune cell populations. Distinct cellular activation and differentiation stages bring varied immune‑surveillance demands, requiring diversified membrane‑embedded lectin‑type receptor glycoproteins to support multicellular tissue physiological equilibrium. Membrane‑localized KLRK1 assembles with partner membrane protein units to counteract aberrant surface‑complex arrangement shifts and help sustain stable plasma‑membrane functional characteristics.
Sequence‑level alterations to the KLRK1 locus may compromise the structural organisation of assembled plasma‑membrane receptor‑partner complexes and alter readouts derived from cell‑surface molecular interaction events. Closely related members of the killer‑cell lectin‑like receptor family cannot fully replicate the complete set of KLRK1‑dependent behaviours during heteromeric surface‑complex formation and stable integration within plasma‑membrane assemblies. Shifts in KLRK1 protein levels often align with cellular demands for immune‑surveillance‑related activities, making this protein a useful research target to explore C‑type‑lectin‑receptor‑family activities and immune‑cell‑surface molecular dynamics. Found primarily on immune‑cell plasma‑membrane compartments, KLRK1 contributes to heteromeric surface‑complex formation and relies on separate adaptor partners rather than maintaining constitutive persistent downstream signalling activity by itself. Its multi‑domain type‑II transmembrane lectin‑fold architecture distinguishes this glycoprotein from many other immune‑associated surface proteins; such structural features support the maintenance of immune‑surface‑complex arrangement and permit selective physical contacts with cell‑surface binding partners. Diminished functional performance of KLRK1 may disturb the proper arrangement of immune‑cell surface assemblies and weaken endogenous cellular adaptive buffering capacity, further supporting its research value for studies focused on killer‑cell lectin‑like receptor components.
Fig. 1 Structural features of human KLRK1(NKG2D) membrane‑receptor complex, illustrating homodimer assembly and the association with DAP10 adaptor subunit carrying intracellular YxxM motif.1
The biological functions of transmembrane KLRK1 glycoprotein are focused on sustained heteromeric partner-complex interaction and plasma-membrane-homeostasis coordination:
Creative Biolabs offers purified KLRK1 membrane samples produced under unified preparation workflows, including full-length KLRK1 constructs and isolated domain variants. Truncated domain fragments cannot support complete surface-partner-complex assembly behaviours, while full-length constructs suit research focused on receptor-subunit-partner interaction and plasma-membrane anchoring functional observation. All batches receive uniform quality screening. Functional-relevant observation may only be carried out with full-length samples under simulated plasma-membrane microenvironment setups. Consistent structural features are preserved across batches to support comparative laboratory analysis across separate test groups. Full-length KLRK1 samples retain intact partner-interaction-domain conformation after standardized purification, which supports reliable detection of weak and transient subunit-partner contacts for comparative functional analysis.
Not finding the membrane protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides adjustable KLRK1 expression cell research models with varied expression levels, applicable to structural observation of type-II transmembrane C-type-lectin-like receptor proteins and research into membrane-partner molecular interaction. Sample evaluation includes sustained target expression detection and preliminary partner-interaction observation, enabling side-by-side comparison of subunit-binding behaviours under differing expression abundances. These cell systems can pair with diverse laboratory analysis schemes to track changes in partner-assembly efficiency alongside shifting target protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-KLRK1 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma-membrane localization mapping and identification of subunit-partner molecular complexes. The antibody series can work alongside common laboratory detection reagents to realize multi-dimensional observation of target distribution within immune-cell-membrane-enriched sample materials.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for KLRK1 research:
KLRK1 might act as a type-II transmembrane C-type-lectin-like receptor protein and participate in heteromeric plasma-membrane complex assembly to modulate immune-cell-surface-complex arrangement and plasma-membrane homeostasis.
KLRK1 expression status could alter membrane-partner-complex assembly efficiency and local plasma-membrane-coupled molecular-interaction balance, serving as a major receptor mediator of immune-surveillance-associated biological processes.
No, KLRK1-associated research reagents from Creative Biolabs are exclusively built for exploring membrane-receptor-dependent immune-surface-complex regulatory mechanisms, and shall not be deployed for any clinical-oriented workflows. These preparations are optimized for basic laboratory investigation and do not satisfy performance benchmarks required for clinical implementation.
Offerings include full-length KLRK1 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on plasma-membrane homeostasis and membrane-receptor-mediated membrane-partner perception.
Laboratory observation schemes may include subunit-partner interaction related tests to analyse molecular-binding associated behaviors under simulated plasma-membrane environments.
